Characterizes phenolic compounds in Capparis spinosa organs, indicating targeted applications for food and pharmaceuticals.
Capparis spinosa is a medicinal plant valued for its polyphenolic content and diverse nutritional and industrial applications, yet detailed information on organ- and developmental stage–specific bioactive compound distribution is limited. This study characterized biochemical and polyphenolic variations across leaves, flowers, flower buds, peduncles, and fruits at different ripening stages (unripe, semi-ripe, and fully ripe) to identify optimal plant parts for targeted uses. Total phenolics, total flavonoids, tannins, carbohydrates, antioxidant capacity, and individual phenolic compounds were quantified by HPLC. Organ-dependent differences were pronounced: flowers and leaves had the highest total phenolics and flavonoids, while fully ripe fruits showed lower levels of these compounds but the highest carbohydrate content (310.33 mg/g). Quercetin predominated in flower buds (2.85 mg/g) and flowers (0.86 mg/g), catechin and gallic acid increased during fruit ripening, peaking at in fully ripe fruits (0.83 and 2.02 mg/g, respectively), and ellagic acid accumulated mainly in flowers (2.85 mg/g) and flower buds. These patterns indicate a metabolic shift during fruit maturation from secondary metabolite biosynthesis toward carbohydrate accumulation and catechin enrichment. Overall, the polyphenolic profile of C. spinosa is strongly organ- and stage-specific, providing useful insights for the targeted selection of plant organs for future food, pharmaceutical, and industrial applications.
No takes yet. Share an insight, caveat, or question.
Mohtashami et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: